Ashot Avagimyan

🇦🇲🇮🇷MD, PhD | Yerevan State Medical University | Isfahan Cardiovascular Research Institute WHO | Supervisors: Nana Pogosova & Nizal Sarrafzadegan

[SABOURETCardiologist @SABOURETCardio]

Congratulations to #AshotAvagymian and #NizaiSarrafradegan who led this work. Congratulations also to all coauthors ☀️

[Francesco Perone @PeroneFrancesco]

Just published our manuscript "Pharmacological prevention in cardio-oncology: from bench-to-bedside" in the "Heart Failure Reviews" Journal.

Our review article aims to consolidate evidence on strategies to mitigate cancer therapy-related cardiovascular toxicity.

[Ashot Avagimyan @DrAvagimyan]

@FedericaFogacci @EJIM_journal @afgcicero @society_eas 🥇

[Federica Fogacci @FedericaFogacci]

🆕 in @EJIM_journal: our review explores #UricAcid as a potential link btw #Cv & #Renal disease
👉https://t.co/AX66jc1O6C
From a forgotten metabolite to a key #player in the cardiorenal continuum: roles in hypertension, #CAD, heart failure, stroke & PAD @afgcicero @society_eas

[Federica Fogacci @FedericaFogacci]

Resistant #Hypertension is tough – but aldosterone may hold the key 🔑
Just after presenting #BaxHTN at #ESCCongress, our new paper in Drugs compares Aldosterone Synthase Inhibitors head-to-head
👉 https://t.co/ZskWB1GVH0
@afgcicero @DrAvagimyan @GiulianoTocciMD @PeroneFrancesco

[Giuseppe Biondi-Zoccai @gbiondizoccai]

Translational aspects of doxorubicin-induced cardiotoxicity: What we have omitted for the past decades? by Ashot Avagimyan et al https://t.co/OgftCJyTLA

[Ashot Avagimyan @DrAvagimyan]

@gbiondizoccai Thank you dear Professor!

[Federica Fogacci @FedericaFogacci]

Our 🆕 review is out in the @EJIM_journal!
In the first part of this series, we explore the dual nature of UA: from antioxidant to pro-inflamm mediator driving endothelial dysf, kidney damage & 🫀 risk. We also discuss the need for personalized targets
📖 https://t.co/JKhD92NpPe

[Arrigo F.G. Cicero @afgcicero]

Here is a critical comment on the need for a tailored revision of daily amounts of vitamins and minerals in dietary supplements! Thanks to the #NFI ! @FedericaFogacci @Unibo

https://t.co/vQSB1YppH9

[Ashot Avagimyan @DrAvagimyan]

@IRanArmed 🇦🇲🇦🇲🇦🇲

[Federica Fogacci @FedericaFogacci]

Step zero before lifestyle changes, meds, or surgery? Read the 🆕 @easociety Consensus!
🔗https://t.co/sA4XrPkYCu
Because being clueless isn’t a treatment strategy 😎
@stefano_romeo76 @DLBHATTMD @j_rvl @LaleTokgozoglu @ProfKausikRay @rex_ahima @LuigiFontanaMD @SusanQuaggin

[Ashot Avagimyan @DrAvagimyan]

I am happy to introduce a new article! It discusses the cardio-, renal-, hepato-, neuro-, and oncoprotective properties of SGLT2i.
🇦🇲🇷🇺🇱🇧🇮🇷
Links: https://t.co/Hw6KYVAis8
Journal: Innovative Medicine of Kuban. We invite you to publish your articles. No APC. Scopus indexed.

[Francesco Perone @PeroneFrancesco]

🚨 Just published our new manuscript "The effect of highly bioavailable forms of curcumin on lipoprotein(a) plasma levels: A systematic review and meta-analysis of randomized clinical studies" in the Prostaglandins and Other Lipid Mediators Journal 🩸
@FedericaFogacci #lpa

[Ashot Avagimyan @DrAvagimyan]

@FedericaFogacci @Cosmofarma 🥇🥇🥇

[Ashot Avagimyan @DrAvagimyan]

@FedericaFogacci The best!!!

[Ashot Avagimyan @DrAvagimyan]

@DFCapodanno This system has been in place in Russia, since the 2000s. Very interesting that a few years ago, some respected lectures from ESC, criticized it :)

[Ashot Avagimyan @DrAvagimyan]

Doxorubicin-induced cardiotoxicity or cardiometabolic disturbances? See our editorial hot off the press!🇦🇲🇷🇺🇮🇹🇮🇷
@FrontiersIn #CardioTwitter #Cardiology #oncology

[SABOURETCardiologist @SABOURETCardio]

Role of #nutrition and healthy #lifestyle, for individuals in #primary prevention: most read article https://t.co/Tb9RUG97kg